Lv3
298 积分 2025-05-07 加入
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP ‐1/ GIP receptor agonist ( BGM0504 ) in healthy volunteers: A dose‐escalation Phase I study
1个月前
已完结
Controlling Gastric Delivery of a GIP/GLP1 Peptide in Monkeys by Mucoadhesive SNAC Tablets
1个月前
已完结
Classification System Proposed to Guide the Design, Development, Regulatory Approval, and Scaling of Long Acting, Small and Macro-Molecule Parenteral Products (CS-BLAP)
6个月前
已完结
Beware of extreme calculated lipophilicity when designing cyclic peptides
8个月前
已完结
Gastrointestinal tract environment and its implications on oral drug delivery
8个月前
已完结
皖公网安备34019202002308
